key: cord-0821815-9el6ix1q
authors: Arcari, Luca; Ciolina, Federica; Cacciotti, Luca; Danti, Massimiliano; Camastra, Giovanni; Manzo, Daniele; Musarò, Salvatore; Pironi, Bruno; Marazzi, Giuseppe; Santini, Claudio; Ansalone, Gerardo; Sbarbati, Stefano
title: Semi-quantitative chest-CT severity score predicts failure of non-invasive positive pressure ventilation in people hospitalized for COVID-19 pneumonia Short title: CT score in COVID-19 pneumonia
date: 2021-09-11
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2021.09.010
sha: 34f51b199788c12630c592b9d2b4d36b190daa14
doc_id: 821815
cord_uid: 9el6ix1q

Objective Non-invasive positive pressure ventilation (NPPV) emerged as an efficient tool for treatment of Coronavirus disease-19 (COVID-19) pneumonia. The factors influencing NPPV failure are still elusive. The aim of the study was to investigate the relationships between semiquantitative chest computed tomography (CT) scoring and NPPV failure and mortality in patients with COVID-19 Design Observational study Setting Non-intensive setting of care Participants N=112 patients consecutively admitted for COVID-19 pneumonia. Interventions Usual care including various degrees of respiratory support Measurements and Main Results The semi-quantitative CT-score was calculated at hospital admission. Subgroups were identified according to the ventilation strategy used (oxygen delivered by Venturi mask n=53; NPPV-responder n=38; NPPV-failure n=21). The study's primary endpoint was the use of NPPV. The secondary endpoints were NPPV failure and in-hospital death, respectively. CT-score progressively increased among groups (6 vs 9 vs 14, p<0.05 between all). CT-score was an independent predictor of all study endpoints (primary endpoint: 1.25 [95% CI 1.1-1.4], p=0.001; NPPV failure: 1.41 [95% CI 1.18-1.69], p<0.001; in-hospital mortality: 1.21 [95% CI 1.07-1.38], p=0.003). According to receiver operator characteristics curve analysis, CT-score was the most accurate variable for prediction of NPPV failure (area under the curve 0.862 with p<0.001; p<0.05 vs other variables). Conclusions We reported the common and effective use of NPPV in patients with COVID-19 pneumonia. In our population, a semi-quantitative chest CT analysis at hospital admission accurately identified those people poorly responding to NPPV.

Coronavirus disease-19 (COVID-19) is a respiratory tract infection burdened by a significant rate of respiratory insufficiency, need for hospitalization and mortality [1] . The novelty and wide spreading of COVID-19 pandemic raised questions on how to effectively manage people with COVID-19 with worsening respiratory insufficiency, that in a non-pandemic setting would have been treated within intensive care units (ICUs). Non-invasive positive pressure ventilation (NPPV) with continuous positive airway pressure or pressure support by helmet or facemask showed to be a reliable tool for treatment of COVID-19 patients even outside ICUs [2] [3] [4] [5] , being associated with substantial beneficial effect especially when used early during hospitalization [6] . On the other hand, the need for and timing of orotracheal intubation (OTI) and mechanical ventilation are still debated [7] . Identification of people with COVID-19 in which NPPV approach will fail is of paramount importance, since it can aid optimal timing for OTI [2] or conversely palliative measures when a do-not-intubate (DNI) indication is present and NPPV itself seems to be associated with lower efficacy [8] . Chest computed tomography (CT) is an effective technique for the diagnosis of COVID-19 pneumonia [9] , while the semi-quantitative evaluation of chest CT findings provides useful prognostic information [10] . However, fewer data are available specifically regarding the influence of increasing lung parenchyma involvement on outcomes of different ventilatory strategies, and the semiquantitative CT assessment still has relatively little validation or widespread clinical use. The aim of the present study was to investigate the accuracy of a CT severity scoring assessment at hospital admission in predicting the response to oxygen therapy (Venturi mask or NPPV) as well as in-hospital outcome in a cohort of patients hospitalized for COVID-19 pneumonia within a non-ICU setting.

This is a single center observational study. Methodology of enrollment and baseline data acquisition in people admitted for COVID-19 pneumonia at our institution have been previously described in detail [11] . We enrolled all patients admitted for COVID-19 pneumonia at our Covid-unit in Vannini hospital. Patients included in the final analysis all had an available chest-CT, arterial blood gas and venous blood examination performed within 24 hours upon admission. Patients with COVID-19 having other prominent acute clinical conditions leading to the index hospital admission (i.e. acute myocardial infarction) or those with no data regarding in-hospital ventilation or without timely chest CT analysis were excluded (Supplementary Figure 1) . The final sample consisted of n=112 patients admitted to a mixed low-and medium-intensity care unit. For the purpose of the present study, we identified subgroups of patients according to the maximum ventilatory support required during hospitalization and its efficacy (oxygen delivered by Venturi mask n=53; successful non-invasive ventilation n=38; failure of non-invasive ventilation n=21). Devices used for non-invasive ventilation included face mask and helmet with or without connection to the ventilator. Modality of NPPV deployment included continuous positive airway pressure with or without pressure support ventilation. The study complied with the declaration of Helsinki; all patients provided written informed consent for the use of their data for research purposes.

The study was approved by the Institutional Review Board.

The study's primary endpoint was the use of NPPV due to worsening respiratory insufficiency. Decision to initiate NPPV was taken by the attending physician according to the current indications [12] . The secondary endpoints were failure of NPPV and in-hospital mortality, respectively. Failure of NPPV was defined as death or need of OTI and mechanical ventilation after initiation of NPPV. The decision to intubate was made by the consultant anesthesiologists on a case-by-case evaluation and largely guided by a simple algorithm available from the literature [13] , which considered oxygen saturation and respiratory rate as the main variables. In our population, every patient who underwent OTI had a trial of NPPV before intubation. Clinicians recording outcome data were blinded to the semi-quantitative radiological evaluation. Outcome data are updated at January 31st, 2021.

We used two multidetector CT scanners (Philips Brilliance 16 and Brilliance 64) for all examinations. Scanning parameters were set as indicated by the manufacturer's standard recommended pre-setting for a thorax routine.

We acquired images with a 1-mm slice thickness and a reconstruction increment of 0,5 mm in all cases using a soft tissue kernel of B20 and a lung kernel of B60. Coronal and sagittal multiplanar reconstructions (MPR) were performed in all cases. Infection prevention and control measures were guaranteed in all suspected CT cases (including sanitation of CT room and patient's isolation). Radiologic findings consistent with SARS-CoV2 pneumonia included three kind of CT patterns: ground glass opacity (GGO), crazy-paving and consolidation [9, 14] A semi-quantitative severity score described in the literature [15] was used per each of the 5 lobes considering the degree of anatomical involvement (0: no involvement; 1: < 5% involvement; 2: 5-25% involvement; 3: 26-50% involvement; 4: 51-75% involvement; 5: >75% involvement). The involvement of each lobe was assessed by the identification of aforementioned abnormalities (GGO, crazy-paving and consolidation) and then visual estimation of their extension (eyeballing). The resulting global CT score was the sum of each individual lobar score (0 to 25). The image analysis, blinded to clinical data, was performed by a radiologist with experience in thoracic radiology by use of the institutional digital database system (Impax Client, Agfa, version 6.6.0.145, Belgium). A further experienced radiologist performed blinded re-reading of images in a subgroup of patients to test for reproducibility of the score.

The distribution of data was assessed by Shapiro-Wilk test. The chi-square, Fisher exact test, Mann-Whitney U test or Kruskall-Wallis test as appropriate were used to compare groups stratified by use and efficacy of ventilatory support. Between groups differences were assessed by post-hoc analysis with Bonferroni correction. Biomarkers values were reported as Log10-transformed in regression analysis to yield an approximate normal distribution.

Univariable and multivariable linear regression analysis were used to investigate factors independently associated with increasing CT severity score. Univariable and multivariable logistic regression analysis were performed to investigate factors independently associated with primary and secondary endpoints, reporting for each variable the standardized beta coefficient (B). Collinearity was tested through correlation matrix, assuming a correlation closer than r= ±0.7 as a proxy of significant collinearity. Multivariable analysis was performed using stepwise method for linear regression and backward for binary logistic regression; this allowed the appropriate reduction of variables included in the final model [16] . Durbin-Watson test was performed confirming the absence of autocorrelations.

Homogeneity of variances has been assessed by the Levene's test. All variables with p<0.05 at univariable analysis were included into the multivariable models. Receiver operator characteristics (ROC) curves were built to assess the ability of different variables in predicting the primary and secondary endpoints, sensitivity and specificity were provided for each variable according to the Youden Index. Comparisons between different ROC curves was performed by Delong test. Interrater reliability of CT severity scoring was assessed in a subgroup of randomly selected patients (n=32) through evaluation by a second expert operator and calculation of Cohen's kappa and interclass correlation coefficient (ICC). All analyses were carried out by using SPSS software version 25 (SPSS inc., Chicago, IL.) and

MedCalc version 19.7 (MedCalc Software, Ostend, Belgium). A two-tailed p<0.05 was considered statistically significant. Table 1 includes baseline characteristics within the overall population as well as in the ventilation subgroups. Mean age was 67±16 years and 62% were male. Comorbidities were common in our population, more than half of the patients had known hypertension and approximately one fourth had pre-existing cardiovascular diseases (11% atrial fibrillation, 10% coronary artery disease, 8% heart failure). Venous blood samples analysis revealed increase of median CRP (6.4 mg/dl, normal value <0.5 mg/dl) and D-dimer (827 ng/ml FEU, normal value <500 ng/ml FEU) as well as decreased lymphocytes count (0.9 per 10 9 /L, normal value >1). On arterial blood gas analysis, mean PaO2 was 77±26 mmHg and median PaO2/FIO2 310 (interquartile range 244, 371). Median chest-CT score was 9±5. In-hospital mortality rate in our population was 25% (n=28).

On subgroups analysis, patients who experienced NPPV failure were significantly older as compared to other groups (p=0.001 for trend), whereas no significant differences were recorded between groups regarding sex and comorbidities distribution. Laboratory tests showed higher CRP in the NPPV failure group as compared to both patients with successful NPPV or low-flow oxygen (10.6 mg/dl vs 7.8 mg/dl vs 3.7 mg/dl, p<0.001 for trend with p<0.05 for difference between NPPV failure and the other groups, depicted in Figure 1A ), whereas no significant D-dimer differences were found between groups (p=0.359, depicted in Figure 1B ). On blood gas analysis, the PaO2/FIO2 was higher in patients who received oxygen by Venturi mask during hospital stay but was similarly reduced in those who underwent successful or unsuccessful NPPV (333 vs 213 vs 219 respectively, p<0.001 for trend, p<0.05 for difference between low-flow oxygen and the other groups, depicted in Figure 1C ). A step wise increase of CT severity score was observed between groups (6 vs 9 vs 14, p<0.001 for trend), with significant differences detected between all groups according to post-hoc analysis (p<0.05, depicted in Figure 1D ). Average time between symptoms onset to CT examination was 7±4 days, not significantly different between groups. No difference in medical therapy between patients with NPPV responder and failure were detected, whereas patients within the Venturi mask group had lower prescription rate of antibiotics and corticosteroids.

The duration of NPPV received was higher in NPPV-failure patients (7 days vs 12 days, p=0.005). OTI rate was 8% overall and 42% in the NPPV failure group. In-hospital death occurred in 8 patients (15%) in the Venturi mask group and 20 (95%) in the NPPV failure group. 

According to the ROC curves analysis, CT score showed at least moderate ability of 

In the present study, we described findings from a cohort of patients with COVID-19 pneumonia having detailed data available regarding in-hospital ventilation strategy, radiologic evaluation and outcome. In a mixed low-and medium-intensity care non-ICU setting, we reported the common use of NPPV which in most of the cases was effective. The semi-quantitative chest-CT assessment at hospital admission provided highly reproducible information with significant prognostic relevance. Furthermore, among the study endpoints, CT score retained the best accuracy in discriminating failure of treatment in those patients allocated to NPPV.

NPPV is increasingly used in patients with COVID-19, even outside the ICUs in the context of increasing pressure on health-care systems driven by the ongoing pandemic [3] . NPPV use in COVID-19 relies on its ability to recruit non-aerated alveoli, reducing extravascular lung water (highly represented within affected lung areas [17] ), increasing functional residual capacity, and reducing work of breathing [18] . NPPV was effective in more than half of the patients allocated to this treatment in our population, a rate comparable to previous studies [18] [19] [20] , which suggests that this strategy might significantly contribute to the clinical management of patients with COVID-19. Allocation to the NPPV strategy (primary endpoint) in our population was not unexpectedly driven by worsening respiratory failure as indicated by PaO2/FIO2 being one of the most accurate predictors of the primary endpoint. PaO2/FIO2 is a fundamental parameter to be assessed in patients with COVID-19, used as measure of disease severity as well as outcome measure in studies testing novel treatments [21, 22] , hence, it was likely one of the major variables guiding clinical decision-making as supported by previous evidence [12] . The independent association that we observed between CT score and the primary endpoint indicates that the radiologic evaluation could potentially integrate blood gas analysis to aid the identification of those patients who should be considered for early NPPV and closer monitoring.

Selection of patients with COVID-19 who will most benefit from a NPPV approach remains of paramount importance. Indeed, when NPPV is considered as a ceiling-of-care therapy, as in the presence of a DNI indication, this would likely provide fewer advantages as compared to the Venturi mask only [8] . On the other hand, Vaschetto et al., reporting data from a large sample of patients with COVID-19 managed in a non-ICU setting, observed how delayed OTI could be a risk factor for mortality [2] . In this context, we found that CT-severity score was the most accurate predictor of NPPV failure in comparison to all other variables, including PaO2/FIO2 or CRP. Moreover, we found higher CT scores in patients with NPPV failure as compared to those in which it was effective, while PaO2/FIO2 did not differ between these subgroups. Based on our findings it could be speculated that, in the presence of respiratory failure of comparable severity on admission, the anatomical substrate might condition responsiveness to NPPV.

We observed a non-trivial rate of in-hospital mortality in our cohort, partly explained by the characteristics of relatively elderly Italian COVID-19 patients [23] , and by inclusion of more severely affected individuals that were directly sent to a medium-intensity care setting.

Though most of the deaths occurred in the context of worsening respiratory failure and after initiation of NPPV, others happened in patients who received oxygen delivered only by Venturi mask during hospital stay. Even though CT-score remained independently associated with the secondary endpoint in-hospital mortality, age had higher accuracy, further reiterating the role of pre-existing underlying conditions of vulnerability portending significant influence on prognosis. Accordingly, we found CT severity score to be independently associated with PaO2/FIO2 and CRP but not with age nor with markers of end-organ damage such as hs-Troponin or creatinine, which suggests that multi-organ damage in COVID-19 might not be entirely justified solely by higher disruption of lung parenchyma and subsequent respiratory insufficiency, but also by systemic non-respiratory involvement influencing prognosis [24] [25] [26] . Of note, after multivariable analysis, CRP failed to be independently associated with any of the study endpoints; however, given the present study's sample size and literature data indicating a prognostic role for CRP in COVID-19 [27] , this result should be carefully interpreted.

Our findings might potentially carry clinical implications. In patient with an available chest-CT at hospital admission, to routinely perform a semi-quantitative evaluation could provide timely information on anatomical lung involvement, to be complemented by the assessment of end-organ damage markers and blood gas analysis in order to improve risk-stratification and provide treatment guidance (i.e. by leading to a lower threshold for NPPV initiation).

Optimal timing of OTI in patients with COVID-19 is still debated [28] [29] [30] , where lung involvement by CT imaging might be considered as an adjunctive factor contributing to this evaluation [7] . Further studies are needed to fully assess whether a more prominent role of semi-quantitative chest CT evaluation in guiding ventilatory treatment approach, with early OTI in patients with major lung anatomical involvement, might be associated with improved prognosis. The usefulness of qualitative analysis, as well as a repeated CT scan during inhospital stay, has been hypothesized [15] , likely providing more accurate information as compared to a semi-quantitative evaluation only; however, limitations related to costs, reproducibility and slowing workflow should be taken into account.

The present study should be read in light of several limitations, including partly retrospective nature, limited sample size and absence of a validation cohort. We acknowledge that our protocol, including routine chest-CT at hospital admission, might not be immediately transferred to other settings with different resources and organization, thus by limiting the generalizability and applicability of our findings. For such reasons, our observational data should be considered as hypothesis generating only, where targeted case-control prospective studies should be performed to effectively demonstrate an advantage of a CT score guided clinical management in COVID-19 patients. Effect-size of CT-score for the association with the primary endpoint and in-hospital mortality were relatively lower if compared to the effect-size for prediction of NPPV failure, suggesting that other factors than extent of lung parenchyma disruption, including age and systemic involvement, highly contribute to determine prognosis in patients with COVID-19. In our sample, all patients had a trial of NPPV before OTI; this is likely explained by the fact that more severely affected patients requiring immediate OTI at hospital admission were directly sent to higher intensity of care wards such as ICUs, being missed by our analysis. Consequently, results from our study might not be immediately transferred to the ICU setting as well as to other populations with markedly different baseline demographic data.

In our population, NPPV was an effective tool for the management of COVID-19 pneumonia related respiratory insufficiency outside ICUs. Semi-quantitative chest CT analysis at hospital admission provided highly reproducible prognostic information, especially in terms of responsiveness to NPPV. Further studies are needed to fully assess whether routine implementation of CT score to guide clinical management might bring advantages in the care of patients with COVID-19 pneumonia.

Ethics approval: study approved by the Institutional Review Board Consent to participate: the patients provided written informed consent to the used of data for research purpose Consent for publication: the patients consented to the publication of anonymized data Availability of data and material: data will be made available upon reasonable request 

A novel coronavirus from patients with pneumonia in China

Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit

Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID)

Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry

Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients

CPAP management of COVID-19 respiratory failure: A first quantitative analysis from an inpatient service evaluation

Indications for Tracheal Intubation in Patients With Coronavirus Disease 2019 (COVID-19)

The role of CPAP as a potential bridge to invasive ventilation and as a ceiling-of-care for patients hospitalized with Covid-19-An observational study

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review

Risk factors for adverse clinical outcomes with COVID-19 in China: A multicenter, retrospective, observational study

Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients

Continuous positive airway pressure in Covid-19 patients with moderate-to-severe respiratory failure

Flowchart for non-invasive ventilation support in COVID-19 patients from a northern Italy Emergency Department

Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients

Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19)

Variable selection strategies and its importance in clinical prediction modelling

Heart and lung involvement detected by native T1 and T2 mapping magnetic resonance imaging in a patient with coronavirus disease-19

Noninvasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2

Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service

Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: Retrospective analysis from a UK teaching hospital

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Early Outcomes with Utilization of Tissue Plasminogen Activator

Associated Respiratory Distress: A series of five cases

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy n

Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

Age and multimorbidity predict death among COVID-19 Patients: Results of the SARS-RAS study of the Italian society of hypertension

Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

Creactive protein and clinical outcomes in patients with COVID-19

Effect of Early vs. Delayed or No Intubation on Clinical Outcomes of Patients With COVID-19: An Observational Study

Early versus late tracheal intubation in COVID-19 patients: a pro-con debate also considering heart-lung interactions

Timing of invasive mechanic ventilation in critically ill patients with coronavirus disease 2019